Exploration of piperidin-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Phenyl derivatives with broad potency against resistant mutant viruses

Roche R&D Center China, Shanghai, China.
Bioorganic & medicinal chemistry letters (Impact Factor: 2.42). 10/2010; 20(20):6020-3. DOI: 10.1016/j.bmcl.2010.08.068
Source: PubMed


Further investigation of the recently reported piperidine-4-yl-aminopyrimidine class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) has been carried out. Thus, preparation of a series of N-phenyl piperidine analogs resulted in the identification of 3-carboxamides as a particularly active series. Analogs such as 28 and 40 are very potent versus wild-type HIV-1 and a broad range of NNRTI-resistant mutant viruses. Synthesis, structure-activity relationship (SAR), clearance data, and crystallographic evidence for the binding motif are discussed.

Download full-text


Available from: Guozhi Tang, Oct 08, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) nowadays represent most promising anti-AIDS drugs that specifically inhibit HIV-1 reverse transcriptase (RT). They have a unique antiviral potency, high specificity and low cytotoxicity. However, to a great extent, the efficacy of HIV-1 NNRTIs is compounded by rapid emergence of drug resistant virus strains, which calls for continuous efforts to develop novel HIV-1 NNRTIs. Diarylpyrimidine (DAPY) derivatives, one family of NNRTIs with superior activity profiles against wild-type HIV-1 and mutant strains, have attracted considerable attention over the past few years. Among the potent lead DAPY compounds, etravirine was approved by FDA in January 2008, and its analogue rilpivirine (TMC278) has advanced to phase III clinical trials. The successful development of DAPYs results from a multidisciplinary approach involving traditional medicinal chemistry, structural biology, crystallography and computational chemistry. Recently, a number of novel characteristics of DAPYs including conformational flexibility, positional adaptability, key hydrogen bonds and specifically targeting conserved residues of RT, have been identified, providing valuable avenues for further optimization and development of new DAPY analogues as promising anti-HIV drug candidates. In this review, we first present a brief historical account of the medicinal chemistry of the DAPY NNRTIs, then focus on the extensive structural modifications, SAR studies, and binding mode analysis based on crystallographic and molecular modeling. Other structural related NNRTI scaffolds will also be reviewed.
    Current Medicinal Chemistry 01/2011; 18(3):359-76. DOI:10.2174/092986711794839142 · 3.85 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this Letter, we report on diarylpyridinone, diarylpyridazinone and diarylphthalazinone analogs as potential inhibitors of HIV-1 nonnucleoside reverse transcriptase (NNRTIs). The most promising compounds in these series are three diarylpyridazinones 25a, 25l and 25n which demonstrated submicromolar activity against wild-type HIV-1 and moderate activity against the single mutant strain Ba-L V106A.
    Bioorganic & medicinal chemistry 09/2011; 19(20):5924-34. DOI:10.1016/j.bmc.2011.08.060 · 2.79 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Chemical preparation, x-ray characterization, IR spectroscopy and thermal analysis of a new sulfate (C7H12O2NH2)4(SO4)2.6H2O, are reported. The atomic arrangement can be described by layers formed by sulfate anions (SO -24) and water molecules connected by hydrogen bonds O-H…O. These inorganic layers are developed around ab planes at z = 0 and z = 1/2 and are interconnected by the H-bonds created by organic groups. All the hydrogen bonds, the Van der waals contacts and electrostatic interactions between the different entities give rise to a three-dimensional network in the structure and add stability to this compound. The thermal behaviour and the IR spectroscopic studies of this new sulfate are discussed.
    E-Journal of Chemistry 10/2011; 8(4). DOI:10.1155/2011/572080 · 0.70 Impact Factor
Show more